Compare GRMN & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRMN | HLN |
|---|---|---|
| Founded | 1990 | 2022 |
| Country | Switzerland | United Kingdom |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Package Goods/Cosmetics |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.8B | 43.7B |
| IPO Year | 2000 | N/A |
| Metric | GRMN | HLN |
|---|---|---|
| Price | $211.67 | $9.85 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 6 | 1 |
| Target Price | ★ $236.00 | N/A |
| AVG Volume (30 Days) | 843.9K | ★ 7.5M |
| Earning Date | 02-18-2026 | 02-26-2026 |
| Dividend Yield | 1.70% | ★ 1.84% |
| EPS Growth | 3.11 | ★ 41.64 |
| EPS | ★ 8.11 | 0.23 |
| Revenue | $6,943,125,000.00 | ★ $15,096,588,575.00 |
| Revenue This Year | $15.64 | $1.51 |
| Revenue Next Year | $6.52 | $4.67 |
| P/E Ratio | $26.12 | ★ $20.80 |
| Revenue Growth | ★ 16.56 | N/A |
| 52 Week Low | $169.26 | $8.71 |
| 52 Week High | $261.69 | $11.42 |
| Indicator | GRMN | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 57.16 | 48.87 |
| Support Level | $209.59 | $9.71 |
| Resistance Level | $214.33 | $10.03 |
| Average True Range (ATR) | 3.49 | 0.13 |
| MACD | 0.66 | -0.05 |
| Stochastic Oscillator | 81.13 | 24.17 |
Garmin produces GPS-enabled hardware and software for five sectors: fitness, outdoors, automotive, aviation, and marine. Garmin has built a strong reputation for durable, high-precision devices through a vertically integrated design and manufacturing approach. The company's product lines include smartwatches, fitness trackers, communication equipment, and a comprehensive suite of systems for marine and aviation navigation. Garmin operates globally, with its business focused primarily on North America and Europe.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.